NCT05836584 2025-12-01Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) CancerNational Cancer Institute (NCI)Phase 2 Active not recruiting240 enrolled